AshrafiG, SchwarzTL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ, 2013; 20(1):31–42; doi: 10.1038/cdd.2012.81
2.
WeiH, LiuL, ChenQ. Selective removal of mitochondria via mitophagy: Distinct pathways for different mitochondrial stresses. Biochim Biophys Acta, 2015; 1853(10 Pt B):2784–2790; doi: 10.1016/j.bbamcr.2015.03.013
3.
BisolLW, BrunsteinMG, OttoniGL, et al.Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia. J Clin Psychiatry, 2008; 69(10):9918.
4.
PatergnaniS, BonoraM, IngusciS, et al.Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis. Proc Natl Acad Sci USA, 2021; 118(24):e2020078118; doi: 10.1073/pnas.2020078118
5.
Contreras-ShannonV, HeartDL, ParedesRM, et al.Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PLoS One, 2013; 8(3):e59012; doi: 10.1371/journal.pone.0059012
6.
KobayashiN, OkaN, TakahashiM, et al.Human herpesvirus 6B greatly increases risk of depression by activating hypothalamic-pituitary -adrenal axis during latent phase of infection. iScience, 2020; 23(6):101187; doi: 10.1016/j.isci.2020.101187
7.
WuwongseS, ChangRC-C, LawACK. The putative neurodegenerative links between depression and Alzheimer's disease. Prog Neurobiol, 2010; 91(4):362–375; doi: 10.1016/j.pneurobio.2010.04.005
8.
KoseE, YoshimuraY, WakabayashiH, et al.Use of Antipsychotics is negatively associated with muscle strength in older adults with sarcopenia after stroke. J Stroke Cerebrovasc Dis, 2022; 31(8):106587; doi: 10.1016/j.jstrokecerebrovasdis.2022.106587
9.
CaleyCF, WeberSS. Sulpiride: An antipsychotic with selective dopaminergic antagonist properties. Ann Pharmacother, 1995; 29(2):152–160; doi: 10.1177/106002809502900210
10.
KohliJD, CripeLD. Sulpiride: A weak antagonist of norepinephrine and 5-hydroxytryptamine. Eur J Pharmacol, 1979; 56(3):283–286; doi: 10.1016/0014-2999(79)90185-7
11.
NamaziM. Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition. J Eur Acad Dermatol Venereol, 2005; 19(3):319–322; doi: 10.1111/j.1468-3083.2004.01184.x
12.
HalevyS, GhislainP-D, MockenhauptM, et al.Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol, 2008; 58(1):25–32; doi: 10.1016/j.jaad.2007.08.036
13.
TripolinoC, CiaffiJ, RuscittiP, et al.Hyperuricemia in psoriatic arthritis: Epidemiology, pathophysiology, and clinical implications. Front Med, 2021; 8:737573; doi: 10.3389/fmed.2021.737573
14.
LingS, CebanF, LuiLMW, et al.Molecular mechanisms of psilocybin and implications for the treatment of depression. CNS Drugs, 2022; 36(1):17–30; doi: 10.1007/s40263-021-00877-y
15.
RobinsonGI, LiD, WangB, et al.Anti-inflammatory effects of serotonin receptor and transient receptor potential channel ligands in human small intestinal epithelial cells. Curr Issues Mol Biol, 2023; 45(8):6743–6774; doi: 10.3390/cimb45080427
16.
MohamedHB, Abd El-HamidBN, FathallaD, et al.Current trends in pharmaceutical treatment of dry eye disease: A review. Eur J Pharm Sci, 2022; 175:106206; doi: 10.1016/j.ejps.2022.106206
17.
McLaughlinPJ, SassaniJW, KlocekMS, et al.Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)–OGF receptor (OGFr) axis with naltrexone: A review. Brain Res Bull, 2010; 81(2):236–247; doi: 10.1016/j.brainresbull.2009.08.008
18.
AbdelkaderH, WuZ, Al-KassasR, et al.Niosomes and discomes for ocular delivery of naltrexone hydrochloride: Morphological, rheological, spreading properties and photo-protective effects. Int J Pharm, 2012; 433(1):142–148; doi: 10.1016/j.ijpharm.2012.05.011
19.
AbdelkaderH, PierscionekB, AlanyRG. Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: Fabrication, mechanical properties, mucoadhesion, tolerability and stability studies. Int J Pharm, 2014; 477(1):631–642; doi: 10.1016/j.ijpharm.2014.10.069
20.
ChiangMC, BowenA, SchierLA, et al.Parabrachial complex: A hub for pain and aversion. J Neurosci, 2019; 39(42):8225–8230; doi: 10.1523/JNEUROSCI.1162-19.2019
21.
BrewerR, MurphyJ, BirdG. Atypical interoception as a common risk factor for psychopathology: A review. Neurosci Biobehav Rev, 2021; 130:470–508; doi: 10.1016/j.neubiorev.2021.07.036
22.
Di LerniaD, SerinoS, TuenaC, et al.Mental health meets computational neuroscience: A predictive Bayesian account of the relationship between interoception and multisensory bodily illusions in anorexia nervosa. Int J Clin Health Psychol, 2023; 23(4):100383; doi: 10.1016/j.ijchp.2023.100383
23.
PauesJ, EngblomD, MackerlovaL, et al.Feeding-related immune responsive brain stem neurons: Association with CGRP. Neuroreport, 2001; 12(11):2399; doi: 10.1097/00001756-200108080-00023
24.
DrakeLA, FallonJD, SoberA. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol, 1994; 31(4):613–616; doi: 10.1016/S0190-9622(94)70225-X
25.
SeanP, SemlerBL. Coxsackievirus B RNA replication: Lessons from poliovirus. Curr Top Microbiol Immunol, 2008; 323:89–121; doi: 10.1007/978-3-540-75546-3_5
26.
NattelS, HeijmanJ, ZhouL, et al.Molecular basis of atrial fibrillation pathophysiology and therapy. Circ Res, 2020; 127(1):51–72; doi: 10.1161/CIRCRESAHA.120.316363
27.
ReiffelJA, NaccarelliGV. Understanding antiarrhythmic drug efficacy for the clinical practitioner: There is more than meets the eye. Am J Med, 2022; 135(7):822–827; doi: 10.1016/j.amjmed.2022.02.019
28.
Kumar DeshmukhF, YaffeD, OlshinaMA, et al.The contribution of the 20S proteasome to proteostasis. Biomolecules, 2019; 9(5):190; doi: 10.3390/biom9050190
29.
ReinheckelT, SitteN, UllrichO, et al.Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J, 1998; 335(3):637–642; doi: 10.1042/bj3350637
Kalev-ZylinskaML, GreenTN, Morel-KoppM-C, et al.N-methyl-d-aspartate receptors amplify activation and aggregation of human platelets. Thromb Res, 2014; 133(5):837–847; doi: 10.1016/j.thromres.2014.02.011
OmerbašićD, SchuhmacherL-N, Bernal SierraY-A, et al.ASICs and mammalian mechanoreceptor function. Neuropharmacology, 2015; 94:80–86; doi: 10.1016/j.neuropharm.2014.12.007
34.
SlukaKA, WinterOC, WemmieJA. Acid-sensing ion channels: A new target for pain and CNS diseases. Curr Opin Drug Discov Devel, 2009; 12(5):693–704.
35.
JeongS, LeeSH, KimYO, et al.Antinociceptive effects of amiloride and benzamil in neuropathic pain model rats. J Korean Med Sci, 2013; 28(8):1238–1243; doi: 10.3346/jkms.2013.28.8.1238
LamanauskasN, NistriA. Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro. Eur J Neurosci, 2008; 27(10):2501–2514; doi: 10.1111/j.1460-9568.2008.06211.x
38.
JahnK, SchlesingerF, JinLJ, et al.Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABAA-receptors. Naunyn-Schmied Arch Pharmacol, 2008; 378(1):53–63; doi: 10.1007/s00210-008-0290-y
39.
KayodeOT, RotimiDE, KayodeAAA, et al.Monosodium glutamate (MSG)-induced male reproductive dysfunction: A mini review. Toxics, 2020; 8(1):7; doi: 10.3390/toxics8010007
40.
YangY, LiQ, HuangR, et al.Small-molecule-driven direct reprogramming of fibroblasts into functional sertoli-like cells as a model for male reproductive toxicology. Adv Biol (Weinh), 2022; 6(5):2101184; doi: 10.1002/adbi.202101184
41.
MattoscioD, EvangelistaV, De CristofaroR, et al.Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response. FASEB J, 2010; 24(10):3970–3980; doi: 10.1096/fj.10-159921
42.
YangH, ZhangC, HuL, et al.Platelet CFTR inhibition enhances arterial thrombosis via increasing intracellular Cl− concentration and activation of SGK1 signaling pathway. Acta Pharmacol Sin, 2022; 43(10):2596–2608; doi: 10.1038/s41401-022-00868-9
43.
TonstadS, AronsC, RollemaH, et al.Varenicline: Mode of action, efficacy, safety and accumulated experience salient for clinical populations. Curr Med Res Opin, 2020; 36(5):713–730; doi: 10.1080/03007995.2020.1729708
44.
AlenNV. The cholinergic anti-inflammatory pathway in humans: State-of-the-art review and future directions. Neurosci Biobehav Rev, 2022; 136:104622; doi: 10.1016/j.neubiorev.2022.104622
45.
WangH, YuM, OchaniM, et al.Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature, 2003; 421(6921):384–388; doi: 10.1038/nature01339
46.
BorovikovaLV, IvanovaS, ZhangM, et al.Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 2000; 405(6785):458–462; doi: 10.1038/35013070
47.
PavlovVA, OchaniM, YangL-H, et al.Selective α7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis*. Crti Care Med, 2007; 35(4):1139; doi: 10.1097/01.CCM.0000259381.56526.96
48.
BarisE, EfeH, GumustekinM, et al.Varenicline prevents LPS-induced inflammatory response via nicotinic acetylcholine receptors in raw 264.7 macrophages. Front Mol Biosci, 2021; 8:721533; doi: 10.3389/fmolb.2021.721533
